Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
NCT03602833Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Nov 2018
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of compound 451238 in soft tissue sarcoma (STS), sponsored by Royal Marsden NHS Foundation Trust. Started Nov 2018; status: completed.
02
Drugs
compound 451238
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT03602833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03602833.